| Dr Gregory Michael Rucker, MD | |
|
700 Center St, Suite 204, Columbus, GA 31901-1546 | |
| (706) 596-1314 | |
| (706) 596-9225 |
| Full Name | Dr Gregory Michael Rucker |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 43 Years |
| Location | 700 Center St, Columbus, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073510905 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 28457 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Columbus Regional Midtown | Columbus, GA | Hospital |
| St Francis Hospital- Emory Healthcare | Columbus, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Internal Medicine Of West-central Georgia, P.c. | 0941298319 | 2 |
News Archive
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
Unitive Design & Analysis Ltd, a London-based SME, announced today their success in being awarded an Innovate UK grant to develop a commercial roadmap for a Quantum Technology- based brain imaging system.
As part of its innovative rehabilitation efforts to assist Operation Iraqi Freedom (OIF)/Operation Enduring Freedom (OEF) military personnel (active duty and non-active) with moderate to severe traumatic brain injury (TBI) and their families, Casa Colina Centers for Rehabilitation is hosting the second session of Survive & Thrive at The Alisal Guest Ranch and Resort in Solvang, CA. The event takes place from April 4 through April 8, 2011.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed a long-term license agreement with Fujirebio Inc. to make its biomarker assay Procalcitonin (PCT) available on the Lumipulse family of laboratory instruments, using the chemiluminescent enzyme immunoassay (CLEIA) technology.
Icotinib has been found to be noninferior to gefitinib in patients with non-small-cell lung cancer, according to reports from the phase III Chinese double-blind ICOGEN study.
› Verified 9 days ago
| Entity Name | Internal Medicine Of West-central Georgia, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154478733 PECOS PAC ID: 0941298319 Enrollment ID: O20040504001045 |
News Archive
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
Unitive Design & Analysis Ltd, a London-based SME, announced today their success in being awarded an Innovate UK grant to develop a commercial roadmap for a Quantum Technology- based brain imaging system.
As part of its innovative rehabilitation efforts to assist Operation Iraqi Freedom (OIF)/Operation Enduring Freedom (OEF) military personnel (active duty and non-active) with moderate to severe traumatic brain injury (TBI) and their families, Casa Colina Centers for Rehabilitation is hosting the second session of Survive & Thrive at The Alisal Guest Ranch and Resort in Solvang, CA. The event takes place from April 4 through April 8, 2011.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed a long-term license agreement with Fujirebio Inc. to make its biomarker assay Procalcitonin (PCT) available on the Lumipulse family of laboratory instruments, using the chemiluminescent enzyme immunoassay (CLEIA) technology.
Icotinib has been found to be noninferior to gefitinib in patients with non-small-cell lung cancer, according to reports from the phase III Chinese double-blind ICOGEN study.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Michael Rucker, MD 700 Center St, Suite 204, Columbus, GA 31901-1546 Ph: (706) 596-1314 | Dr Gregory Michael Rucker, MD 700 Center St, Suite 204, Columbus, GA 31901-1546 Ph: (706) 596-1314 |
News Archive
According to a new major study one in eight children born with HIV becomes resistant to the three main classes of drugs used to suppress the virus within five years of starting treatment. This is the first major study that looks at drug resistance in 1,000 European children born with HIV. It raises questions about the suitability of anti-retroviral drugs for the young.
Unitive Design & Analysis Ltd, a London-based SME, announced today their success in being awarded an Innovate UK grant to develop a commercial roadmap for a Quantum Technology- based brain imaging system.
As part of its innovative rehabilitation efforts to assist Operation Iraqi Freedom (OIF)/Operation Enduring Freedom (OEF) military personnel (active duty and non-active) with moderate to severe traumatic brain injury (TBI) and their families, Casa Colina Centers for Rehabilitation is hosting the second session of Survive & Thrive at The Alisal Guest Ranch and Resort in Solvang, CA. The event takes place from April 4 through April 8, 2011.
Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has signed a long-term license agreement with Fujirebio Inc. to make its biomarker assay Procalcitonin (PCT) available on the Lumipulse family of laboratory instruments, using the chemiluminescent enzyme immunoassay (CLEIA) technology.
Icotinib has been found to be noninferior to gefitinib in patients with non-small-cell lung cancer, according to reports from the phase III Chinese double-blind ICOGEN study.
› Verified 9 days ago
Andrew N Vernon, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2122 Manchester Expy, Columbus, GA 31904 Phone: 706-320-2773 Fax: 706-596-4226 | |
Dr. Christopher Morgan Lee, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Center St, Suite 204, Columbus, GA 31901 Phone: 706-596-1314 Fax: 706-596-9225 | |
Dr. James Lacey Smith, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1207 Marina Cove Dr, Columbus, GA 31904 Phone: 901-412-1881 | |
Srividya Srinivasamaharaj, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1831 5th Ave, Columbus, GA 31904 Phone: 706-320-8780 Fax: 706-320-8721 | |
Dr. Mylena E Morton, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 710 Center St, Columbus, GA 31901 Phone: 706-571-1262 Fax: 706-660-6512 | |
Da Monica Alethea Cannon, NP Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2737 Warm Springs Rd Ste C, Columbus, GA 31904 Phone: 706-571-1136 |